Kodiak Sciences Inc. (KOD) Financials

KOD Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 306.0 million 193.9 million
Dec. 31, 2025 351.5 million 194.2 million
Sept. 30, 2025 218.1 million 194.4 million
June 30, 2025 256.7 million 186.4 million

KOD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -41.0 million 12.2 million
Dec. 31, 2025 -39.4 million 27.3 million
Sept. 30, 2025 -32.9 million 14.0 million
June 30, 2025 -34.8 million 15.6 million

KOD Net Income

No data available :(

KOD Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 169.5 million 44.3 million 56.0 million
Dec. 31, 2025 209.9 million 47.1 million 59.2 million
Sept. 30, 2025 72.0 million - 62.2 million
June 30, 2025 104.2 million - 65.2 million

KOD Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 61.9 million
Dec. 31, 2025 53.2 million
Sept. 30, 2025 52.9 million
June 30, 2025 52.8 million

KOD Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 942000 48.5 million 11.2 million -
Dec. 31, 2025 43000 45.5 million 12.0 million -
Sept. 30, 2025 59999 50.5 million 11.9 million -
June 30, 2025 133000 42.8 million 12.8 million -

KOD Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 6.3 million
Dec. 31, 2025 - -19.8 million
Sept. 30, 2025 - 6.5 million
June 30, 2025 - 6.5 million

KOD

Price: $34.16

52 week price:
2.81
47.84

Earnings Per Share: -4.17 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 76500

Market Capitalization: 2.2 billion

Links: